{
    "organizations": [],
    "uuid": "5b58fca83afd9c9efe2cf127ca8687a39ad5f283",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-karyopharm-therapeutics-reports-q1/brief-karyopharm-therapeutics-reports-q1-loss-per-share-of-0-78-idUSASC0A1CO",
    "ord_in_thread": 0,
    "title": "BRIEF-Karyopharm Therapeutics Reports Q1 Loss Per Share Of $0.78",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Karyopharm Therapeutics Inc:\n* KARYOPHARM REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PROGRESS\n* Q1 LOSS PER SHARE $0.78 * Q1 EARNINGS PER SHARE VIEW $-0.62 â€” THOMSON REUTERS I/B/E/S\n* PLANS TO SUBMIT NDA REQUESTING ACCELERATED APPROVAL FOR SELINEXOR IN PENTA-REFRACTORY MYELOMA DURING SECOND HALF OF 2018\n* KARYOPHARM THERAPEUTICS - ORAL SELINEXOR ACHIEVES 25.4% ORR AND MEDIAN DURATION OF RESPONSE OF 4.4 MONTHS IN PATIENTS WITH PENTA-REFRACTORY MYELOMA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T19:18:00.000+03:00",
    "crawled": "2018-05-11T12:47:29.054+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "karyopharm",
        "therapeutic",
        "inc",
        "karyopharm",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "highlight",
        "recent",
        "progress",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "plan",
        "submit",
        "nda",
        "requesting",
        "accelerated",
        "approval",
        "selinexor",
        "myeloma",
        "second",
        "half",
        "karyopharm",
        "therapeutic",
        "oral",
        "selinexor",
        "achieves",
        "orr",
        "median",
        "duration",
        "response",
        "month",
        "patient",
        "myeloma",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}